David V. Goeddel, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 130,000 shares at $3.79 ($462K) on 2022-10-18, disclosed to the SEC on 2022-10-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.18 | 50,000 | $159K | 34.4% |
| 2 | $3.79 | 80,000 | $303K | 65.6% |
| Total | $3.56 avg | 130,000 | $462K | 100% |
| Filing → |
| NGM | BUY | 2023-11-17 | $18K | — | Filing → |
| TNYA | BUY | 2023-03-14 | $18K | — | Filing → |
| TNYA | BUY | 2023-02-10 | $3.9M | — | Filing → |